Clinical updates, including trial initiations, enrollment status and data readouts and publications: Azurrx, Bioinvent, Concentric, Eucure, Gesynta, I-Mab, Isa, Imvax, Lilly, Marinus, Merck, Minoryx, Morphosys, Myovant, Orphomed, Qurient, Regeneron, Rhythm, Vir.